Stories written by

R Ramakumar

As Indian government offers some answers on Covaxin patent rights, more questions emerge

Since the government shares rights with Bharat Biotech, why did it not initiate steps to mass produce this vaccine in India over the past several months?

R Ramakumar
· May 12, 2021 · 07:45 pm
State governments can purchase only 25% of vaccines – belying Centre’s claim of equitable policy

There is also a clear case of discrimination in the new vaccine policy, given that the burden of deregulation is disproportionately borne by state governments.

R Ramakumar
· May 11, 2021 · 11:30 am
Whose intellectual property is Bharat Biotech’s publicly funded Covaxin? India deserves an answer

If it turns out that the ICMR or the government owns the rights, the Indian public has the right to know how these were leveraged during a pandemic.

R Ramakumar
· Apr 26, 2021 · 06:30 am